Sensible Biotechnologies And Ginkgo Bioworks Announce Partnership To Make In Vivo RNA To Unlock The Promise Of RNA Therapeutics Coaxing cells to produce mRNA for therapeutic applications has been an unsuccessful endeavor so far. Miroslav Gasparek is on a mission to use synbio to change that. His company Sensible Biotechnologies is partnering with Ginkgo Bioworks to develop the next generation of mRNA therapeutics.